Lv1
29 积分 2023-10-09 加入
Reply to "Concerns regarding stem cell mobilization in liposomal mitoxantrone therapy for relapsed/refractory T-cell/natural killer-cell lymphomas"
1天前
待确认
Concerns regarding stem cell mobilization in liposomal mitoxantrone therapy for relapsed/refractory T-cell/natural killer-cell lymphomas
1天前
已完结
Rituximab-Chidamide combination chemotherapy enhances autophagy to overcome drug resistance in diffuse large B-cell lymphoma
3天前
已完结
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
4天前
已完结
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)
4天前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
4天前
已完结
Are there clinically relevant prognostic factors in diffuse large B-cell lymphoma beyond International Prognostic Index?
5天前
已关闭
HDAC family: What are the cancer relevant targets?
6天前
已完结
The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo
10天前
已完结
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma
10天前
已完结
Development and Characterization of Methyl-Anthranilate-Loaded Silver Nanoparticles: A Phytocosmetic Sunscreen Gel for UV Protection
1年前
已采纳
Synthesis of Fe3O4/PDA Nanocomposites for Osteosarcoma Magnetic Resonance Imaging and Photothermal Therapy
1年前
已采纳
皖公网安备34019202002308
